Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | 1 | X018278 | — |
the patients have not experienced any ill effects; This office manager reports that expired PNEUMOVAX 23 was administered to two patients on 12Feb2025.; This spontaneous report has been received from a regarding a health professional regarding a 77-year-old male patient. Information regarding medical history, concurrent conditions and concomitant therapies was not reported. On 12-FEB-2025, the patient received Pneumococcal Vaccine, Polyvalent (23-valent) Solution for injection (PNEUMOVAX 23) for prophylaxis, lot number X018278 which has been verified to be valid, expiration date reported and validated as 24-NOV-2024 (scheme, dose, strength, anatomical site, route of administration not provided) (expired vaccine used). The patient have not experienced any ill effects (no adverse event).